Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-22

Clinical Trial Update: Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Strattera (atomoxetine) for children with ADHD who have a poor response to stimulant therapy has completed. This update notes the statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: ADHD | Phase 4 | Status: COMPLETED